Annual Retained Earnings
-$211.12 M
-$12.85 M-6.48%
March 1, 2024
Summary
- As of February 8, 2025, GRCE annual retained earnings is -$211.12 million, with the most recent change of -$12.85 million (-6.48%) on March 1, 2024.
- During the last 3 years, GRCE annual retained earnings has fallen by -$65.10 million (-44.58%).
- GRCE annual retained earnings is now -5807.74% below its all-time high of -$3.57 million, reached on February 1, 2010.
Performance
GRCE Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$217.17 M
-$3.43 M-1.61%
September 1, 2024
Summary
- As of February 8, 2025, GRCE quarterly retained earnings is -$217.17 million, with the most recent change of -$3.43 million (-1.61%) on September 1, 2024.
- Over the past year, GRCE quarterly retained earnings has dropped by -$9.21 million (-4.43%).
- GRCE quarterly retained earnings is now -5977.01% below its all-time high of -$3.57 million, reached on February 1, 2010.
Performance
GRCE Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
GRCE Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.5% | -4.4% |
| 3 y3 years | -44.6% | -31.4% |
| 5 y5 years | -109.4% | -75.3% |
GRCE Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -44.6% | at low | -42.9% | at low |
| 5 y | 5-year | -109.4% | at low | -71.9% | at low |
| alltime | all time | -5807.7% | at low | -5977.0% | at low |
Grace Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$217.17 M(+1.6%) |
| Jun 2024 | - | -$213.74 M(+1.2%) |
| Mar 2024 | -$211.12 M(+6.5%) | -$211.12 M(+1.5%) |
| Dec 2023 | - | -$207.95 M(+1.2%) |
| Sep 2023 | - | -$205.56 M(+1.6%) |
| Jun 2023 | - | -$202.29 M(+2.0%) |
| Mar 2023 | -$198.27 M(+27.2%) | -$198.27 M(+17.2%) |
| Dec 2022 | - | -$169.18 M(+2.4%) |
| Sep 2022 | - | -$165.29 M(+3.1%) |
| Jun 2022 | - | -$160.36 M(+2.9%) |
| Mar 2022 | -$155.84 M(+6.7%) | -$155.84 M(+2.6%) |
| Dec 2021 | - | -$151.93 M(+2.6%) |
| Sep 2021 | - | -$148.16 M(-0.7%) |
| Jun 2021 | - | -$149.14 M(+2.1%) |
| Mar 2021 | -$146.02 M(+15.6%) | -$146.02 M(+4.0%) |
| Dec 2020 | - | -$140.37 M(+2.3%) |
| Sep 2020 | - | -$137.15 M(+4.7%) |
| Jun 2020 | - | -$131.01 M(+3.7%) |
| Mar 2020 | -$126.34 M(+25.3%) | -$126.34 M(-8.2%) |
| Dec 2019 | - | -$137.62 M(+11.1%) |
| Sep 2019 | - | -$123.92 M(+19.9%) |
| Jun 2019 | - | -$103.37 M(+2.5%) |
| Mar 2019 | -$100.83 M(+79.9%) | -$100.83 M(+28.2%) |
| Dec 2018 | - | -$78.66 M(-0.9%) |
| Sep 2018 | - | -$79.36 M(+30.8%) |
| Jun 2018 | - | -$60.68 M(+8.3%) |
| Mar 2018 | -$56.05 M(+46.9%) | -$56.05 M(+9.7%) |
| Dec 2017 | - | -$51.08 M(+9.0%) |
| Sep 2017 | - | -$46.88 M(+13.6%) |
| Jun 2017 | - | -$41.25 M |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | -$38.15 M(+30.5%) | - |
| Nov 2016 | - | -$35.36 M(+2.6%) |
| Aug 2016 | - | -$34.46 M(+5.1%) |
| May 2016 | - | -$32.80 M(+12.2%) |
| Feb 2016 | -$29.24 M(+9.8%) | -$29.24 M(+3.7%) |
| Nov 2015 | - | -$28.20 M(+5.1%) |
| Aug 2015 | - | -$26.82 M(-2.8%) |
| May 2015 | - | -$27.58 M(+3.6%) |
| Feb 2015 | -$26.62 M(-6.4%) | -$26.62 M(-1.6%) |
| Nov 2014 | - | -$27.06 M(-13.5%) |
| Aug 2014 | - | -$31.28 M(+12.0%) |
| May 2014 | - | -$27.92 M(-1.9%) |
| Feb 2014 | -$28.45 M(+45.3%) | -$28.45 M(+3.8%) |
| Nov 2013 | - | -$27.41 M(+14.5%) |
| Aug 2013 | - | -$23.95 M(+12.2%) |
| May 2013 | - | -$21.35 M(+9.1%) |
| Feb 2013 | -$19.58 M(+48.0%) | -$19.58 M(+7.5%) |
| Nov 2012 | - | -$18.21 M(+9.7%) |
| Aug 2012 | - | -$16.60 M(+16.1%) |
| May 2012 | - | -$14.29 M(+8.0%) |
| Feb 2012 | -$13.23 M(+94.5%) | -$13.23 M(+18.1%) |
| Nov 2011 | - | -$11.20 M(+16.8%) |
| Aug 2011 | - | -$9.59 M(+22.2%) |
| May 2011 | - | -$7.85 M(+15.4%) |
| Feb 2011 | -$6.80 M(+90.3%) | -$6.80 M(-46.7%) |
| Nov 2010 | - | -$12.77 M(+9.0%) |
| Aug 2010 | - | -$11.71 M(+3.6%) |
| May 2010 | - | -$11.30 M(+216.2%) |
| Feb 2010 | -$3.57 M | -$3.57 M(-66.1%) |
| Nov 2009 | - | -$10.55 M |
FAQ
- What is Grace Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Grace Therapeutics?
- What is Grace Therapeutics annual retained earnings year-on-year change?
- What is Grace Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Grace Therapeutics?
- What is Grace Therapeutics quarterly retained earnings year-on-year change?
What is Grace Therapeutics annual retained earnings?
The current annual retained earnings of GRCE is -$211.12 M
What is the all time high annual retained earnings for Grace Therapeutics?
Grace Therapeutics all-time high annual retained earnings is -$3.57 M
What is Grace Therapeutics annual retained earnings year-on-year change?
Over the past year, GRCE annual retained earnings has changed by -$12.85 M (-6.48%)
What is Grace Therapeutics quarterly retained earnings?
The current quarterly retained earnings of GRCE is -$217.17 M
What is the all time high quarterly retained earnings for Grace Therapeutics?
Grace Therapeutics all-time high quarterly retained earnings is -$3.57 M
What is Grace Therapeutics quarterly retained earnings year-on-year change?
Over the past year, GRCE quarterly retained earnings has changed by -$9.21 M (-4.43%)